Monthly body composition scans allow the clinical team to continuously monitor progress, adjust medication dosing, modify nutritional plans, and fine-tune exercise recommendations based on objective, measurable data rather than guesswork
[1] [4] In the type 2 diabetes cohort, retatrutide also produced clinically meaningful weight loss alongside reductions in HbA1c
The absolute contraindications (thyroid cancer history, MEN2) are rare conditions
Its funny, youll read how almost no nutrients make it down to where the GLP-1 producing cells are, under normal situations. But by normal they mean, donuts for breakfast
Cardiovascular outcomes: In clinical studies of patients with type 2 diabetes and established heart disease, semaglutide reduced the risk of certain cardiovascular events
In the US, FDA-approved drugs that are in shortage can be legally compounded by 503A and 503B pharmacies